ANNJI PHARMACEUTICAL <7754.TWO> SUBMITS APPLICATION TO U.S. FDA FOR PHASE 3 CLINICAL TRIAL OF AJ201 FOR KENNEDY’S DISEASE

Reuters · 3d ago

Please log in to view news